Normotensive group (n=185) | Pre-eclampsia group (n=97) | p Value | |
Gestational age, weeks, median (IQR) | 29 (26–30) | 29 (28–30) | 0.01 |
Birth weight (g), median (IQR) | 1207 (900–1425) | 1020 (785–1250) | 0.00 |
IUGR, n (%) | 6 (3) | 33 (35) | 0.00 |
SNAP-PE score, median (IQR) | 18 (9–32) | 19 (9–36) | 0.80 |
Males, n (%) | 104 (56) | 47 (49) | 0.13 |
Inotrope use, n (%) | 51 (28) | 17 (18) | 0.04 |
RDS, n (%) | 142 (77) | 74 (76) | 0.52 |
Surfactant use, n (%) | 96 (52) | 58 (60) | 0.12 |
PDA, n (%) | 75 (40) | 39 (40) | 0.53 |
Any IVH, n (%) | 24 (13) | 11 (13) | 0.42 |
Severe IVH, n (%) | 7 (4) | 2 (2) | 0.34 |
Culture-proven sepsis, n (%) | 31 (17) | 8 (8) | 0.03 |
Blood transfusion, n (%) | 60 (32) | 19 (19) | 0.15 |
BPD at 36 weeks, n (%) | 55 (30) | 23 (24) | 0.35 |
NEC stage ≥2, n (%) | 10 (5) | 3 (3) | 0.28 |
Duration of oxygen use (days), median (IQR) | 13 (2–57) | 8 (2–48) | 0.27 |
Duration of ventilation (days), median (IQR) | 1 (0–7) | 1 (0–5) 9.36 | 0.68 |
Any ROP, n (%) | 50 (27) | 26 (27) | 0.54 |
Severe ROP,* n (%) | 17 (9) | 4 (4) | 0.09 |
*>Stage 2 and/or plus disease.
BPD, bronchopulmonary dysplasia; IUGR, intrauterine growth restriction; IVH, intraventricular haemorrhage; NEC, necrotising enterocolitis; PDA, patent ductus arteriosus; RDS, respiratory distress syndrome; ROP, retinopathy of prematurity; SNAP-PE, Score for Neonatal Acute Physiology-Physiological Extension.